HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rhabdoid tumor of the kidney: complete remission induced by cis-platinum and adriamycin.

Abstract
A 4-month-old male infant with Stage I rhabdoid tumor of the kidney at presentation subsequently developed pulmonary metastatic disease shortly after diagnosis and initiation of Vincristine and Actinomycin D chemotherapy. The patient was then treated with cis-platinum and Adriamycin. Within 28 days he achieved a complete remission which was maintained for 5 months. Subsequent recurrent pulmonary lesions failed to regress with radiotherapy and high-dose cyclophosphamide when used as single sequential agents. Further clinical trials with cis-platinum and Adriamycin seem warranted since prognosis with this tumor is poor and successful chemotherapy after metastatic dissemination has not been previously reported.
AuthorsM Roper, R T Parmley, W M Crist, D R Kelly, C H Hyland, M Salter
JournalMedical and pediatric oncology (Med Pediatr Oncol) Vol. 9 Issue 2 Pg. 175-80 ( 1981) ISSN: 0098-1532 [Print] United States
PMID6262611 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Doxorubicin
  • Cisplatin
Topics
  • Cisplatin (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Drug Therapy, Combination
  • Humans
  • Infant
  • Kidney Neoplasms (drug therapy, pathology)
  • Lung Neoplasms (secondary)
  • Male
  • Wilms Tumor (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: